Drugs / Oxiconazole Nitrate
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | OXISTAT | — | 1992-09-30 – 1997-08-18 | fda.gov ↗ |
| Approved | US (FDA) | OXISTAT | — | 1988-12-30 | fda.gov ↗ |
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03823040 | Jul → Dec 2018 | tinea infection | Minia University | Completed | No outcome recorded |
| Phase 1 | NCT01519752 | Nov 2011 → Aug 2012 | tinea pedis | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxiconazole Nitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01519752 ↗ |
| Known as | Oxistat | “Oxiconazole Nitrate Cream 1% (Oxistat®)” NCT01519752 ↗ |
| Route | Topical | “Oxiconazole Nitrate Cream 1% applied to affected area once a day for 28 days” NCT01519752 ↗ |